Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-19

Clinical Trial Update: Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and equivalence of a generic ciclopirox olamine 0.77% cream compared with reference ciclopirox cream for tinea pedis has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox cream (reference) (ciclopirox)
  • Ciclopirox olamine 0.77% cream (generic) (ciclopirox olamine)

Snippet

Sponsor: Padagis LLC | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-19